A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors
Clinical trial NCT02847637 · COMPLETED
Trial details
- NCT number
- NCT02847637
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-27
- Primary completion
- 2017-09-15
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.